Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
107 studies found for:    interstitial lung disease AND children
Show Display Options
Rank Status Study
21 Unknown  Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis
Interventions: Drug: bosentan;   Other: No specific intervention
22 Recruiting Tagrisso Tablets Clinical Experience Investigation (All Case Investigation)
Condition: All Patients Treated With the Product
Intervention:
23 Completed A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy
Conditions: Lung Cancer;   Tuberculosis;   Sarcoidosis;   Interstitial Lung Disease
Interventions: Drug: 1% lignocaine;   Drug: 2% lignocaine
24 Completed Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs)
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: Biological DMARDs;   Drug: Non-Biologic DMARDs
25 Completed The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate Symptoms
Condition: HIV Infections
Intervention: Drug: Zidovudine
26 Completed Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases
Conditions: Lung Diseases;   Pulmonary Fibrosis;   Lung Diseases, Interstitial;   Scleroderma, Systemic
Intervention:
27 Completed Idiopathic Pulmonary Fibrosis: a Case-control Study
Conditions: Lung Diseases;   Pulmonary Fibrosis;   Lung Diseases, Interstitial
Intervention:
28 Completed Lung Diffusing Capacity for Nitric Oxide as a Marker of Fibrotic Changes in Idiopathic Interstitial Pneumonias
Conditions: Usual Interstitial Pneumonia;   Nonspecific Interstitial Pneumonia
Intervention:
29 Terminated Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE)
Conditions: Bronchopulmonary Dysplasia;   Respiratory Distress Syndrome;   Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature
Interventions: Procedure: Minimal mechanical ventilation management;   Procedure: Routine mechanical ventilation management;   Drug: Dexamethasone;   Drug: Placebo
30 Recruiting A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia
Condition: Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis
Intervention: Drug: Prograf
31 Completed Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists
Conditions: Hospitalized Cases of Angioneurotic Oedema;   Pneumonia;   Gastroenteritis;   Failure to Thrive;   Seizures;   Acute Interstitial Nephritis and Thrombocytopenia
Intervention:
32 Unknown  Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus
Conditions: Interstitial Pneumonitis;   Polymyositis;   Dermatomyositis
Intervention: Drug: Tacrolimus
33 Recruiting Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis;   Familial Pulmonary Fibrosis;   Idiopathic Interstitial Pneumonia;   Familial Interstitial Pneumonia
Intervention:
34 Terminated DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)
Conditions: Pneumonia, Interstitial Plasma Cell;   Pneumocystis Carinii Pneumonia;   Pneumonia, Pneumocystis Carinii;   HIV Infections
Interventions: Drug: Pafuramidine maleate (DB289);   Drug: Trimethoprim-Sulfamethoxazole (TMP-SMX)
35 Unknown  Respiratory Endoscopy: Diagnostic Yield, Technical Factors and Complications
Conditions: Lung Neoplasm;   Lung Diseases, Interstitial;   Respiratory Tract Infections;   Pleural Effusions
Intervention: Procedure: Respiratory endoscopy
36 Completed Herpesvirus in Idiopathic Pulmonary Fibrosis
Conditions: Lung Diseases;   Herpesvirus Infections
Intervention:
37 Terminated An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF
Conditions: Idiopathic Pulmonary Fibrosis;   Pulmonary Fibrosis;   Lung Disease
Intervention: Drug: Interferon gamma-1b
38 Completed Specialized Center of Research in Occupational and Immunologic Lung Disease
Conditions: Lung Diseases, Obstructive;   Asbestosis;   Silicosis;   Pneumoconiosis;   Chronic Obstructive Pulmonary Disease
Intervention:
39 Recruiting LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis
Interventions: Drug: Prednisone;   Drug: Vinblastine;   Drug: mercaptopurine;   Drug: INDOMETHACIN;   Drug: Methotrexate;   Drug: Cytosine Arabinoside;   Drug: 2-chlorodeoxyadenosine;   Procedure: hematopoietic stem cell transplantation (RIC-HSCT);   Biological: Intravenous immunoglobulin
40 Recruiting Nandrolone Decanoate in the Treatment of Telomeropathies
Conditions: Aplastic Anemia;   Bone Marrow Failure Syndromes;   Idiopathic Pulmonary Fibrosis;   Telomere Shortening
Intervention: Drug: Nandrolone Decanoate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.